Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
Johnson & Johnson Slipping Ahead Of Q3 Earnings; Shares At Key Support Level
Seeking Alpha
Thu, 10/11/12 - 10:40 am
earnings
JNJ
Former Synthes Execs Excluded From Federal Healthcare Programs
Pharmalot
Wed, 10/10/12 - 11:43 am
JNJ
Synthes
Medicare
Medicaid
Eli Lilly Sees A Ray Of Hope But The Stock Is Ahead Of Itself
Seeking Alpha
Wed, 10/10/12 - 11:37 am
Eli Lilly
AstraZeneca
GSK
JNJ
Merck
Pfizer
J&J eyes new Doxil process to reverse shortage
Fierce Pharma
Tue, 10/9/12 - 11:16 am
Doxil
JNJ
drug shortages
FDA
EMA
Johnson & Johnson's Mishaps Mask A Great Business At A Reasonable Price
Seeking Alpha
Tue, 10/9/12 - 09:49 am
JNJ
Pfizer Won't Get A Slap On The Wrist From The SEC
Seeking Alpha
Tue, 10/9/12 - 09:47 am
Pfizer
SEC
GSK
JNJ
Merck
Novartis
J&J's $74 Value Hinges On Medical Devices Growth And Pharma Pipeline
Mon, 10/8/12 - 08:35 pm
JNJ
New Diabetes Drug Can Bolster J&J’s $74 Value
Trefis
Sat, 10/6/12 - 12:05 pm
JNJ
diabetes
canagliflozin
type 2 diabetes
J&J's $74 Value Hinges On Medical Devices Growth And Pharma Pipeline
Forbes
Fri, 10/5/12 - 11:20 am
JNJ
Former FDA chief says J&J broke law promoting Risperdal, Philly Inquirer says
Yahoo/Fly on the Wall
Thu, 10/4/12 - 10:55 am
FDA
JNJ
Risperdal
Celgene's Pipeline Offers Catalysts Into 2013
Seeking Alpha
Thu, 10/4/12 - 10:43 am
Celgene
JNJ
Bristol-Myers Squibb
Roche
ONYX Pharmaceuticals
Abraxane
Eli Lilly
J&J and Astellas Collaborate
Yahoo/Zacks
Thu, 10/4/12 - 10:42 am
JNJ
Astellas
JAK inhibitors
ASP015K
rheumatoid arthritis
Opko's 4KScore Could Generate Over $1.8 Billion Annually
Seeking Alpha
Wed, 10/3/12 - 12:34 pm
GSK
JNJ
OPKO Health
Merck
Novartis
Pfizer
Sanofi
prostate cancer
4Kscore
J&J Experimental Diabetes Drug Helps High-Risk Patients
Bloomberg
Tue, 10/2/12 - 10:05 am
diabetes
JNJ
canagliflozin
Dapagliflozin
Bristol-Myers Squibb
AstraZeneca
[video] The Next Big Thing in Biotech: Hepatitis Drugs
TheStreet.com
Fri, 09/28/12 - 10:18 am
hepatitis C
Abbott Labs
Gilead Sciences
JNJ
Merck
Vertex Pharmaceuticals
Idenix
Achillion
Pfizer, Merck Ink Deals In China To Make Up For Shrinking Revenue
Seeking Alpha
Thu, 09/27/12 - 11:34 am
Pfizer
Merck
China
GSK
JNJ
Zhejiang Hisun Pharma
Novartis
J&J Pushed Risperdal With Golf, Popcorn, Witness Says
Bloomberg
Tue, 09/25/12 - 03:59 pm
JNJ
Risperdal
antipsychotics
How Many Pharmas Does It Take to Accelerate Drug Development?
Motley Fool
Tue, 09/25/12 - 10:04 am
drug development
Abbott Labs
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
GSK
JNJ
Pfizer
Roche
Sanofi
TransCelerate BioPharma
Valuing Drug Stocks
Seeking Alpha
Sat, 09/22/12 - 03:38 pm
JNJ
Merck
Pfizer
Abbott Laboratories
Johnson & Johnson: Cautiously Optimistic At $68 A Share
Seeking Alpha
Fri, 09/21/12 - 11:32 am
JNJ
Pages
« first
‹ previous
…
130
131
132
133
134
135
136
137
138
…
next ›
last »